Ischemic Heart Disease News and Research

RSS
ACC releases updated appropriate use criteria for coronary revascularization in SIHD patients

ACC releases updated appropriate use criteria for coronary revascularization in SIHD patients

Study finds 78% postoperative stroke reduction with ‘no-touch’ beating heart bypass surgery

Study finds 78% postoperative stroke reduction with ‘no-touch’ beating heart bypass surgery

Deaths from diabetes in the U.S. higher than estimated, study shows

Deaths from diabetes in the U.S. higher than estimated, study shows

Hypertensive disease of pregnancy linked to higher risk for early mortality

Hypertensive disease of pregnancy linked to higher risk for early mortality

VTCRI scientist receives $2.1 million grant for research to combat heart disease

VTCRI scientist receives $2.1 million grant for research to combat heart disease

New comprehensive study lists top personal health expenses in the U.S.

New comprehensive study lists top personal health expenses in the U.S.

Global high blood pressure has almost doubled over past 40 years, shows study

Global high blood pressure has almost doubled over past 40 years, shows study

New study reports both young men and women with ACS have good one-year prognosis

New study reports both young men and women with ACS have good one-year prognosis

Duke, Wisconsin and UAB researchers create bioengineered patches to treat heart failure

Duke, Wisconsin and UAB researchers create bioengineered patches to treat heart failure

PACIFIC study may offer guidance to choose from number of non-invasive coronary artery imaging

PACIFIC study may offer guidance to choose from number of non-invasive coronary artery imaging

MILabs to provide new hybrid imaging system to Yale for advancing cardiovascular research

MILabs to provide new hybrid imaging system to Yale for advancing cardiovascular research

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Low level of physical fitness in early life associated with Type 2 Diabetes risk in adulthood

Low level of physical fitness in early life associated with Type 2 Diabetes risk in adulthood

High-intensity exercise may promote permanent structural changes in the heart

High-intensity exercise may promote permanent structural changes in the heart

ACC, AHA support implementation of proposed cardiovascular measures, with reservations

ACC, AHA support implementation of proposed cardiovascular measures, with reservations

African-American patients with connective tissue diseases at risk for cardiovascular disease

African-American patients with connective tissue diseases at risk for cardiovascular disease

Study reveals increased mortality risk following hypertensive disease of pregnancy

Study reveals increased mortality risk following hypertensive disease of pregnancy

New doctoral thesis reveals potential treatment for stress-induced cardiomyopathy

New doctoral thesis reveals potential treatment for stress-induced cardiomyopathy

Study explores prevalence of myocardial scars in middle-aged and older population

Study explores prevalence of myocardial scars in middle-aged and older population

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.